Bio-Works Technologies AB (XSAT:BIOWKS) Interest Expense: kr0.09 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:BIOWKS Bio-Works Technologies AB XSAT:BIOWKS
69 GF Score
Price kr3.49
GF Value kr3.41
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Bio-Works Technologies AB Interest Expense?

Bio-Works Technologies AB XSAT:BIOWKS +7.06% 69 Interest Expense is kr0.09 Mil as of Jun. 2026. GuruFocus rates XSAT:BIOWKS with a GF Score™ of 69/100 and a GF Value™ of kr3.41 (Fairly Valued). The stock has 2 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Bio-Works Technologies AB's interest expense for the three months ended in Jun. 2026 was kr 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2026 was kr0.09 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Bio-Works Technologies AB's Operating Income for the three months ended in Jun. 2026 was kr -3.07 Mil. Bio-Works Technologies AB's Interest Expense for the three months ended in Jun. 2026 was kr 0.00 Mil. Bio-Works Technologies AB has no long-term debt (1). The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Bio-Works Technologies AB  (XSAT:BIOWKS) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bio-Works Technologies AB's Interest Expense for the three months ended in Jun. 2026 was kr0.00 Mil. Its Operating Income for the three months ended in Jun. 2026 was kr-3.07 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2026 was kr0.00 Mil.

Bio-Works Technologies AB's Interest Coverage for the quarter that ended in Jun. 2026 is calculated as

Bio-Works Technologies AB had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Bio-Works Technologies AB has no debt.

Bio-Works Technologies AB Interest Expense Historical Data

* Premium members only.

The historical data trend for Bio-Works Technologies AB's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Works Technologies AB Interest Expense Chart

Bio-Works Technologies AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 -0.02 -0.00 -0.01 -0.00

Bio-Works Technologies AB Quarterly Data
Mar20 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 -0.13 0.22 0.00 0.00
XSAT:BIOWKS
69GF Score
Bio-Works Technologies AB XSAT:BIOWKS
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio-Works Technologies AB Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of kr0.09 Mil mean?
Bio-Works Technologies AB (XSAT:BIOWKS) has a Interest Expense of kr0.09 Mil as of Jun. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Bio-Works Technologies AB and its competitors.
Is Bio-Works Technologies AB's Interest Expense too high?
Bio-Works Technologies AB's current Interest Expense is kr0.09 Mil. Overall, Bio-Works Technologies AB has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bio-Works Technologies AB's Interest Expense compare to ISRG and BDX?
Bio-Works Technologies AB's Interest Expense of kr0.09 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Medical Devices & Instruments company?
A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Bio-Works Technologies AB and its competitors. Bio-Works Technologies AB's current Interest Expense is kr0.09 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Works Technologies AB stock overvalued right now?
Based on GuruFocus' analysis, Bio-Works Technologies AB (XSAT:BIOWKS) is currently considered Fairly Valued. The stock's GF Value™ is kr3.41, compared to a current price of kr3.49 — trading 2.3% above its estimated fair value. The current Interest Expense is kr0.09 Mil. Bio-Works Technologies AB's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Bio-Works Technologies AB (XSAT:BIOWKS), the current Interest Expense is kr0.09 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio-Works Technologies AB (XSAT:BIOWKS) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Works Technologies AB stock appears to be overvalued. The current stock price of kr3.49 is trading 2.3% above its estimated GF Value™ of kr3.41. GuruFocus considers Bio-Works Technologies AB to be Fairly Valued.

Key valuation signals for XSAT:BIOWKS:

  • Interest Expense: kr0.09 Mil
  • GF Value™: kr3.41 vs. price of kr3.49 (2.3% above fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the XSAT:BIOWKS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bio-Works Technologies AB Business Description

Other Exchanges 1BD:Germany
Address Virdings alle 18, Uppsala, SWE, 75450
Bio-Works Technologies AB is a Sweden-based life science company which is engaged in designing, developing, manufacturing and supplying products for purification and separation of proteins and other molecules. The product line of the company includes activated resin, immobilized metal-ion affinity chromatography resin, ion exchange chromatography resin, size exclusion chromatography resin and others. The company has also developed affinity chromatography technique, BabyBio Columns, OptiBio glass columns for separating proteins, and protein purification. Bio-Works serves various end users such as academic research laboratories, biopharmaceutical companies, the food and beverage industry and others.
69GF Score

Get the complete analysis for XSAT:BIOWKS

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.49
Price
kr3.41
GF Value